in pentoperazole capsules usp why assay value is substract
from dissolution
- 1 Answers
- 3429 Views
- Ranbaxy, I also Faced
- E-Mail Answers
Answer Posted / dnyaneshwar
In case of Pentaprazole Enteric coated Tablet,As per USP ( % Released at Acid stage = Assay - Content after acid stage ).
Solution : Petaprazole molecules is very unstable in 0.1 M HCl i.e highly degraded.At the time of acid stage dissolution,the release of pentaprazole will start to degrade very fastly.Release & degradation rate take place simultaneously.Thus to determine actual released at acid dissolution after 2 hrs we can determine by above formula
| Is This Answer Correct ? | 0 Yes | 0 No |
Post New Answer View All Answers
how you start RS method development when for new product?
how you determine moist.of NaOH sol or NaOH flacks
how you confirm the assay method?
we can use expired sample for validation and analyst qualification?
please explian me about area normalisation method,diluted standard method,impurity vs impurity and which one has to be selected in method development
How they found 1mL of K.F reagent is equivalent to 5mg of water and if we change the composition of K.F reagent, is it can neutralize more amount of water?
We use hicrome 10 cxs column in hplc analysis....pls tell me.. what is the meaning of 10 cxs?
What is control room temperature and which guide line says?
In which situation we require to analytical method validation of excipient?
How can we calculate offset value pH measurment
why cone formation during dissolution?
Which parameters require to do in tech transfer?
how much mass should be there in volumetric flask while in preparation of sample for assay?
What is similarity factor and its use in api strength?
How do we fix the sample concentaryion in hplc method development?
